Lai; Chiajen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lai; Chiajen.The latest application filed is for "methods of preparing 1'-cyano nucleosides".

Company Profile

4.15.23

Lai; Chiajen - Livermore CA
Lai; Chiajen - Princeton NJ
Lai; Chiajen - Kendall Park NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline forms of tenofovir alafenamide Grant 11,440,928 - Lai , et al. September 13, 2	2022-09-13
Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidaz- o[1,2-a]pyrazin-8-amine as Syk inhibitors Grant 11,339,168 - Andres , et al. May 24, 2	2022-05-24
Methods Of Preparing 1'-cyano Nucleosides App 20210309689 - Badalov; Pavel R. ; et al.	2021-10-07
Solid Forms Of A Syk Inhibitor App 20200291035 - Andres; Patricia ; et al.	2020-09-17
Crystalline forms of darunavir Grant 10,407,438 - Lai , et al. Sept	2019-09-10
Crystalline Forms Of Tenofovir Alafenamide App 20190233448 - Lai; Chiajen ; et al.	2019-08-01
Crystalline forms of tenofovir alafenamide Grant 10,287,307 - Lai , et al.	2019-05-14
Crystalline Forms Of Tenofovir Alafenamide App 20180265530 - Lai; Chiajen ; et al.	2018-09-20
Crystalline Forms Of Darunavir App 20180170945 - Lai; Chiajen ; et al.	2018-06-21
Crystalline Form App 20170217952 - Lai; Chiajen ; et al.	2017-08-03
Crystal structures of SGLT2 inhibitors and processes for preparing same Grant 9,453,039 - Gougoutas , et al. September 27, 2	2016-09-27
Methods Of Producing C-aryl Glucoside Sglt2 Inhibitors App 20140243517 - Deshpande; Prashant P. ; et al.	2014-08-28
Crystal Structures Of Sglt2 Inhibitors And Processes For Preparing Same App 20130303467 - Gougoutas; Jack Z. ; et al.	2013-11-14
Crystal structures of SGLT2 inhibitors and processes for preparing same Grant 8,501,698 - Gougoutas , et al. August 6, 2	2013-08-06
Methods of Producing C-Aryl Glucoside SGLT2 Inhibitors App 20110201795 - Deshpande; Prashant P. ; et al.	2011-08-18
Crystal Structures Of Sglt2 Inhibitors And Processes For Preparing Same App 20110172176 - Gougoutas; Jack Z. ; et al.	2011-07-14
Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein Grant 7,968,718 - Soundararajan , et al. June 28, 2	2011-06-28
Methods of producing C-aryl glucoside SGLT2 inhibitors Grant 7,932,379 - Deshpande , et al. April 26, 2	2011-04-26
Crystal structures of SGLT2 inhibitors and processes for preparing same Grant 7,919,598 - Gougoutas , et al. April 5, 2	2011-04-05
Formulations Of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl- )-1h-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione App 20100292246 - Gu; Chong-Hui ; et al.	2010-11-18
Method of preparation of azaindole derivatives Grant 7,820,820 - Liu , et al. October 26, 2	2010-10-26
Process For Preparing Triazole Substituted Azaindoleoxoacetic Piperazine Derivatives And Novel Salt Forms Produced Therein App 20100076191 - SOUNDARARAJAN; NACHIMUTHU ; et al.	2010-03-25
Process for the preparation of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2, 1-F][1,2,4]triazin-6-yloxy]-1-methylethyl ester Grant 7,671,199 - Crispino , et al. March 2, 2	2010-03-02
Method Of Preparation Of Azaindole Derivatives App 20090312549 - LIU; WANSHENG ; et al.	2009-12-17
Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein Grant 7,601,715 - Soundararajan , et al. October 13, 2	2009-10-13
Method of preparation of azaindole derivatives Grant 7,598,380 - Liu , et al. October 6, 2	2009-10-06
Methods of producing C-aryl glucoside SGLT2 inhibitors Grant 7,375,213 - Deshpande , et al. May 20, 2	2008-05-20
Crystal Structures Of Sglt2 Inhibitors And Processes For Preparing Same App 20080004336 - Gougoutas; Jack Z. ; et al.	2008-01-03
PROCESS FOR THE PREPARATION OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TR- IAZIN-6-YLOXY]-1-METHYLETHYL ESTER App 20070249610 - Crispino; Gerard A. ; et al.	2007-10-25
Methods Of Producing C-aryl Glucoside Sglt2 Inhibitors App 20070238866 - Deshpande; Prashant P. ; et al.	2007-10-11
Method of preparation of azaindole derivatives App 20070032503 - Liu; Wansheng ; et al.	2007-02-08
Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein App 20060293304 - Soundararajan; Nachimuthu ; et al.	2006-12-28
Process for preparing novel crystalline forms of (2S)-1-[[(7R)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyr- imidine-6-yl]carbonyl]-2-(4-fluorophenyl)pyrrolidine, novel stable forms produced therein and formulations App 20060128726 - Wang; Xuebao ; et al.	2006-06-15
Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl- )-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione App 20060100209 - Gu; Chong-Hui ; et al.	2006-05-11
Pharmaceutical tablet having a high api content App 20040208924 - Sprockel, Omar Leopold ; et al.	2004-10-21
Control of compactibility through cystallization App 20040175419 - Sprockel, Omar Leopold ; et al.	2004-09-09
Methods of producing C-aryl glucoside SGLT2 inhibitors App 20040138439 - Deshpande, Prashant P. ; et al.	2004-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.